Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe2O4/silica/cisplatin nanocomposite formulation.

Jermy BR, Ravinayagam V, Alamoudi WA, Almohazey D, Dafalla H, Hussain Allehaibi L, Baykal A, Toprak MS, Somanathan T.

Beilstein J Nanotechnol. 2019 Nov 12;10:2217-2228. doi: 10.3762/bjnano.10.214. eCollection 2019.

2.

Application of Three-dimensional (3D) Tumor Cell Culture Systems and Mechanism of Drug Resistance.

Shehzad A, Ravinayagam V, AlRumaih H, Aljafary M, Almohazey D, Almofty S, Al-Rashid NA, Al-Suhaimi EA.

Curr Pharm Des. 2019;25(34):3599-3607. doi: 10.2174/1381612825666191014163923.

PMID:
31612821
3.

Role of Lipid Rafts in Hematopoietic Stem Cells Homing, Mobilization, Hibernation, and Differentiation.

Alomari M, Almohazey D, Almofty SA, Khan FA, Al Hamad M, Ababneh D.

Cells. 2019 Jun 22;8(6). pii: E630. doi: 10.3390/cells8060630. Review.

4.

Targeted delivery of poly (methyl methacrylate) particles in colon cancer cells selectively attenuates cancer cell proliferation.

Khan FA, Akhtar S, Almohazey D, Alomari M, Almofty SA, Badr I, Elaissari A.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1533-1542. doi: 10.1080/21691401.2019.1577886.

PMID:
31007071
5.

The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching.

Abdulazeez S, Sultana S, Almandil NB, Almohazey D, Bency BJ, Borgio JF.

PLoS One. 2019 Feb 15;14(2):e0212492. doi: 10.1371/journal.pone.0212492. eCollection 2019.

6.

Isolation, Culture, and Functional Characterization of Human Embryonic Stem Cells: Current Trends and Challenges.

Khan FA, Almohazey D, Alomari M, Almofty SA.

Stem Cells Int. 2018 Aug 26;2018:1429351. doi: 10.1155/2018/1429351. eCollection 2018. Review.

7.

Extracts of Clove (Syzygium aromaticum) Potentiate FMSP-Nanoparticles Induced Cell Death in MCF-7 Cells.

Khan FA, Akhtar S, Almohazey D, Alomari M, Almofty SA.

Int J Biomater. 2018 Aug 23;2018:8479439. doi: 10.1155/2018/8479439. eCollection 2018.

8.

Fluorescent magnetic submicronic polymer (FMSP) nanoparticles induce cell death in human colorectal carcinoma cells.

Khan FA, Akhtar S, Almohazey D, Alomari M, Almofty SA, Eliassari A.

Artif Cells Nanomed Biotechnol. 2018;46(sup3):S247-S253. doi: 10.1080/21691401.2018.1491476. Epub 2018 Jul 25.

PMID:
30043653
9.

FMSP-Nanoparticles Induced Cell Death on Human Breast Adenocarcinoma Cell Line (MCF-7 Cells): Morphometric Analysis.

Khan FA, Akhtar S, Almofty SA, Almohazey D, Alomari M.

Biomolecules. 2018 May 23;8(2). pii: E32. doi: 10.3390/biom8020032.

10.

Impact of nanoparticles on neuron biology: current research trends.

Khan FA, Almohazey D, Alomari M, Almofty SA.

Int J Nanomedicine. 2018 May 9;13:2767-2776. doi: 10.2147/IJN.S165675. eCollection 2018. Review.

11.

The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1.

Almohazey D, Lo YH, Vossler CV, Simmons AJ, Hsieh JJ, Bucar EB, Schumacher MA, Hamilton KE, Lau KS, Shroyer NF, Frey MR.

Cell Death Differ. 2017 May;24(5):855-865. doi: 10.1038/cdd.2017.27. Epub 2017 Mar 17.

12.

ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation.

Schumacher MA, Hedl M, Abraham C, Bernard JK, Lozano PR, Hsieh JJ, Almohazey D, Bucar EB, Punit S, Dempsey PJ, Frey MR.

Cell Death Dis. 2017 Feb 23;8(2):e2622. doi: 10.1038/cddis.2017.42.

13.

ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.

Williams CS, Bernard JK, Demory Beckler M, Almohazey D, Washington MK, Smith JJ, Frey MR.

Carcinogenesis. 2015 Jul;36(7):710-8. doi: 10.1093/carcin/bgv049. Epub 2015 Apr 27.

14.

Fibroblast growth factor 10 alters the balance between goblet and Paneth cells in the adult mouse small intestine.

Al Alam D, Danopoulos S, Schall K, Sala FG, Almohazey D, Fernandez GE, Georgia S, Frey MR, Ford HR, Grikscheit T, Bellusci S.

Am J Physiol Gastrointest Liver Physiol. 2015 Apr 15;308(8):G678-90. doi: 10.1152/ajpgi.00158.2014. Epub 2015 Feb 26.

15.

The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.

McElroy SJ, Castle SL, Bernard JK, Almohazey D, Hunter CJ, Bell BA, Al Alam D, Wang L, Ford HR, Frey MR.

Am J Pathol. 2014 Oct;184(10):2768-78. doi: 10.1016/j.ajpath.2014.06.015. Epub 2014 Sep 9.

Supplemental Content

Loading ...
Support Center